Absorica Ld patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9750711 SUN PHARM Low dose oral pharmaceutical composition of isotretinoin
May, 2035

(11 years from now)

US9700535 SUN PHARM Oral pharmaceutical composition of isotretinoin
Aug, 2035

(11 years from now)

Absorica Ld is owned by Sun Pharm.

Absorica Ld contains Isotretinoin.

Absorica Ld has a total of 2 drug patents out of which 0 drug patents have expired.

Absorica Ld was authorised for market use on 05 November, 2019.

Absorica Ld is available in capsule;oral dosage forms.

The generics of Absorica Ld are possible to be released after 04 August, 2035.

Drugs and Companies using ISOTRETINOIN ingredient

Market Authorisation Date: 05 November, 2019

Treatment: NA


More Information on Dosage

ABSORICA LD family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic